Director Nicos Katsoulis of OceanFirst Financial Corp filed a Form 4 on November 2, 2026, disclosing a purchase of 10,000 shares of common stock on October 30, 2026, at a weighted average price of $17.8277 per share.
Director J. Ralph Borneman Jr. filed a Form 4 with the SEC on November 2, 2026, reporting the acquisition of 65 Directors' Deferred Compensation Share Credits in Erie Indemnity Company on October 31, 2026.
A Form 4 filed on November 2, 2026 by director Monica Weakley of AGNT, Inc. (NASDAQ:AGNT) reports the acquisition of 9 shares of common stock on October 31, 2026 under the company's Agent Equity Program.
Director Richard E. Allison Jr. filed a Form 4 with the SEC on November 2, 2026, reporting the disposition of all directly held Kenvue Inc. common stock and deferred share units upon the closing of Kenvue's acquisition by Kimberly-Clark Corporation.
Officer Lydia Ann Ramirez-Medina filed a Form 144 notice on November 2, 2026, disclosing a proposed sale of 4,037 shares of Five Star Bancorp common stock on Nasdaq.
Orchestra BioMed Holdings, Inc. officer and director Darren Sherman filed a Form 144 notice on November 2, 2026, proposing to sell 15,000 shares of common stock through Fidelity Brokerage Services LLC on NASDAQ.
Director Bethany Mayer of Lam Research Corp filed a Form 144 notice of proposed sale of 719 shares of common stock, submitted on November 2, 2026, with an approximate sale date of November 2, 2026.
Vin Menon, Co-Chief Executive Officer of Apimeds Pharmaceuticals US, Inc., filed an initial statement of beneficial ownership on November 2, 2026, reporting a derivative securities position tied to a date-of-event of December 1, 2025.
Bender Investment Company, a 10% owner of Cactus Inc, filed a Form 144 notice on November 2, 2026, proposing the sale of 100,000 shares of Cactus Inc Class A Common Stock on the NYSE.
Timothy M. Martin, an officer of CubeSmart, filed a Form 144 notice of proposed sale of 36,765 common shares on November 2, 2026, in connection with a stock option exercise.